Sentence examples for capsules n from inspiring English sources

Study Design: Sixty-four women in the second half of pregnancy who were not in labor randomly received 10 mg nifedipine tablets (n = 55 studies) or 10 mg nifedipine capsules (n = 74 studies) if blood pressure was ≥170/110 mm Hg.

We compared the participants who took 1 capsule (N = 36) to those who took 2 capsules (N = 63) per day.

Categories and sample numbers were: small tree size with few fruits (SF, 30 60 cm diam, ≤15 capsules, n = 8); small size with many fruits (SM, 30 60 cm diam, >15 capsules, n = 5); large with few fruits (LF, 60 100 cm diam, ≤15 capsules, n = 5); and large with many fruits (LM, 60 100 cm diam, >15 capsules, n = 7).

All subjects entered on their usual diet (pre-treatment, n = 20) and then were randomly assigned to receive either one active 10 mg montelukast tablet and 10 placebo fish oil capsules (n = 10) or one placebo montelukast tablet and 10 active fish oil capsules totaling 3.2 g EPA and 2.0 g DHA (n = 10) taken daily for 3-wk.

Siliphos capsules (n = 28) (Thorne Research, Dover, ID) were analyzed using a modification of previously described methods to ensure purity and content.

Thirteen of the nipple cultures were positive and ten women were randomized to receive flucloxacillin (n = 5) or placebo capsules (n = 5).

Apart from the 54 sterile plants, most individuals developed one capsule (n = 124, 69 ± 45 seeds), eight plants two capsules (112 ± 97 seeds), seven plants three capsules (333 ± 97 seeds), and one plant four capsules (263 seeds).

The atypical areas included anterolateral/beneath the thyroid capsule (n = 1); thymus/thyrothymic ligament (n = 5); and posteromedial and associated with thyroid nodule (n = 1).

Poor metabolizers who received 120 mg BID of tivantinib did not experience any DLT during the DLT observation period, irrespective of capsule (n = 3) or tablet (n = 3) formulations.

9 Extensive metabolizers who received 120 mg BID of tivantinib did not experience any DLT during the DLT observation period, irrespective of the capsule (n = 6) or tablet (n = 6) formulation.

After this discussion and reading the standardized informed consent, 7 were excluded since they were not eligible for screening, and 124 of the remaining 147 persons decided to undergo either colonoscopy (n = 34) or capsule (n = 90), while 23 finally opted against both forms of endoscopic screening.